Furthermore, we found that higher PAN3-AS1 levels was linked to inferior PFI and DFI in three tumor types-ACC, prostate adenocarcinoma (PRAD) and COAD (Fig. 2B,C). This evidence concerns the gene PAN3 and prostate adenocarcinoma.